Orthogem was founded on the observation that the manufacturing methods for conventional SBGs produce a microstructure which, although similar in appearance to cancellous bone, simply does not produce the appropriate environment for bone regeneration Orthogem's ground breaking and patented Tripore technology platform has enabled the creation of a pipeline of SBGs formulated for a variety of clinical applications, ranging from spinal to oral cranial facial surgery Orthogem's scientists designed TriPore from the bottom up by first considering what the optimal microstructure for osteogenic activity should be Based in Nottingham's acclaimed BioCity, Orthogem is proud to have developed it's unique Tripore technology and produced validated preclinical proof, achieving full CE certification, FDA approval and ISO 13485 accreditation Our goal is to establish Orthogem's Technology Platform as the new generation of Synthetic Bone Graft